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Background
The purpose of this case report was to present the extreme
difficulties in finding a solution for the patient with sepsis
treatment determined by bacteria associations: MRSA,
ESBL K pneumoniae, E coli with ESBL.
Case report
We present the case report of a 68-year old male patient,
with a history of prostate cancer surgery, relapsed and
irradiated. Microbiological and antibiogram data, and the
parameters of organ dysfunction represented the basis
for an “extreme” decision in the antibiotherapy scheme.
We obtained microbiological control and we successfully
managed the vital dysfunctions.
Conclusion
Desperate situations sometimes require last resort deci-
sions, extremely costly which can save the patient for the
moment; the question we ask ourselves is whether this
control is also supported and for how long.
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